Abstract-In isolated canine epicardial coronary arteries perfused with Krebs Henseleit solution at 37°C, DN-9693, a newly synthesized selective cyclic AMP phosphodiesterase inhibitor, induced vasodilation in a dose-related manner. The threshold dose for inducing vasodilation to DN-9693 was very small, but the maxi mum vasodilation was not great. The order of potency for ED20 (20% dilatation) was DN-9693>IBMX>
It has been well recognized that inhibitors of cyclic nucleotide phosphodiesterase (PDE) induce a vasodilation via an intracellular in crease in cyclic AMP in the vasculature. In 1985, DN-9693 was developed as one of the water-soluble platelet aggregation inhibitors (1) . Moreover, DN-9693 has been demon strated to inhibit selectively cyclic AMP PDE (isozyme III) in platelets (2) . It was also re ported that DN-9693 might exert its cardio protective action by preventing adhesion and aggergation of leukocytes and platelets (3) (4) (5) . More recently, Hashimoto et al. (6) reported that DN-9693 and isobutylmethylxanthine (IBMX) increased blood flow in a similar dose range with intraarterial injection to the canine coronary, femoral, mesenteric and renal arterial beds. They observed vasodilating effects of DN-9693 in resistance vessels because they investigated the vascular re sponses of in situ arterial preparations (6) . In the present study, we attempted to observe the effects of DN-9693, a selective cyclic AMP PDE inhibitor, comparing them with those of non-selective PDE inhibitors, IBMX and aminophylline, on epicardial large coronary arteries of dogs that were perfused with Krebs-Henseleit solution. The method was developed as the cannula inserting method by Hongo and Chiba (7) .
Mongrel dogs (7-18 kg) of either sex were anesthetized with sodium pentobarbital (30 mg/kg, i.v.). After i.v. injection of sodium heparin (200 units/kg), the dogs were killed by rapid bleeding. The left epicardial coronary artery was isolated from the heart and cleaned of loose adipose and connective tissues in cold Krebs-Henseleit solution (4-10°C).
The artery was cut into segments (0.7 2.6 mm in outside diameter and 1.5 cm length). Side branches were tied with silk threads. The arterial segment was carefully cannulated with a stainless steel cannula (0.6-2.2 mm outer diameter) and was set up for perfusion vs. previously described (8) . Krebs-Henseleit solution was perfused with a peristaltic pump (Harvard Apparatus 505 1210). The flow rate was kept constant through the experiments (approximately 2 ml /min). The basal perfusion pressure was between 60-200 mmHg. The pressure changes were measured with an electric manometer (Nihon Kohden AP621 G). The drug solution was administered into the rubber tube connecting the cannula in a volume of 10-30 tcl for 4 sec by a micro injector (Terumo Co.). Vasodilation, therefore, was recorded as a decrease in perfusion pressure. Krebs-Henseleit solution contained 118 mM NaCI, 4.7 mM KCI, 1.2 mM MgSO4, 2.5 mM CaCI2, 1.2 mM KH2PO4, 25 mM NaHC03 and 11 mM glucose; it was gassed with a mixture of 95% 02 and 5% CO2 and maintained at 37°C (Haake EF2). The ex periments were started when the arteries had equilibrated for about 1 hr, until perfusion pressure increased spontaneously and a stable base line appeared.
Drugs used were DN-9693 (7-pyper idinyl-1,2,3,5-tetrahydroimidazo [2,1b]-2 one hydrochloride) (Daiichi Seiyaku), IBMX (Aldrich Chemical) and aminophylline (Eisai Co., Ltd.). These drugs were dissolved in and diluted with 0.9% saline to the desired con centrations.
Statistical significance between two data samples was tested by Student's t-test. A probability level of P<0.05 was con sidered statistically significant. When DN-9693 was bolusly injected into the cannulated, isolated dog coronary artery, a decrease in perfusion pressure was dose dependently produced. IBMX and aminophyl line also induced dose-related vasodilations. Typical response patterns to the 3 compounds are shown in Fig. 1 
